NATR: Nature's Sunshine Products, Inc. Stock

by  •  • Comments Off on NATR: Nature's Sunshine Products, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 362.37
Enterprise Value ($M) 285.70
Book Value ($M) 159.54
Book Value / Share 8.49
Price / Book 2.27
NCAV ($M) 75.58
NCAV / Share 4.02
Price / NCAV 4.79

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.10

Liquidity (mrq)
Quick Ratio 1.29
Current Ratio 2.16

Balance Sheet (mrq) ($M)
Current Assets 165.82
Assets 249.77
Liabilities 90.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 445.32
Operating Income 24.45
Net Income 15.08
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 41.23
Cash from Investing -10.48
Cash from Financing -7.96

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Paradigm Capital Management Inc/ny 2.87 -51.30
01-31 13G/A Prescott Group Capital Management, L.l.c. 9.40 0.02

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-22 6,185 38,737 15.97
2024-04-19 5,641 26,772 21.07
2024-04-18 6,175 26,647 23.17
2024-04-17 6,544 37,013 17.68

(click for more detail)

Similar Companies
MTEM – Molecular Templates, Inc. MYMD – MyMD Pharmaceuticals, Inc.
MYNZ – Mainz Biomed N.V. NBSE – NeuBase Therapeutics, Inc.
NERV – Minerva Neurosciences, Inc.


Financial data and stock pages provided by
Fintel.io